The PR says the FDA wants further study in that se
Post# of 144713
Really the same as CD10. Leronlimab shows a benefit for the sickest people in the study but they probably aren't a population size large enough to move the needle for regulatory confirmation.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)